25.34
price down icon2.80%   -0.73
after-market Dopo l'orario di chiusura: 25.40 0.06 +0.24%
loading
Precedente Chiudi:
$26.07
Aprire:
$26.06
Volume 24 ore:
2.21M
Relative Volume:
0.63
Capitalizzazione di mercato:
$4.68B
Reddito:
$637.78M
Utile/perdita netta:
$239.40M
Rapporto P/E:
21.28
EPS:
1.1909
Flusso di cassa netto:
$307.21M
1 W Prestazione:
+3.30%
1M Prestazione:
-8.62%
6M Prestazione:
-63.46%
1 anno Prestazione:
-61.58%
Intervallo 1D:
Value
$25.05
$26.16
Intervallo di 1 settimana:
Value
$23.84
$27.09
Portata 52W:
Value
$23.53
$76.51

Doximity Inc Stock (DOCS) Company Profile

Name
Nome
Doximity Inc
Name
Telefono
(650) 549-4330
Name
Indirizzo
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Name
Dipendente
830
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
DOCS's Discussions on Twitter

Compare DOCS vs VEEV, TEM, BTSG, HQY, WAY

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Health Information Services icon
DOCS
Doximity Inc
25.34 4.82B 637.78M 239.40M 307.21M 1.1909
Health Information Services icon
VEEV
Veeva Systems Inc
195.49 32.23B 3.08B 860.33M 1.35B 5.1463
Health Information Services icon
TEM
Tempus Ai Inc
52.26 9.48B 1.27B -245.03M -245.36M -1.4071
Health Information Services icon
BTSG
Brightspring Health Services Inc
41.49 8.08B 11.99B 24.18M 234.31M 0.2956
Health Information Services icon
HQY
Healthequity Inc
78.36 6.83B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
25.71 5.09B 906.14M -52.62M 89.62M -0.3621

Doximity Inc Stock (DOCS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2026-02-09 Aggiornamento Canaccord Genuity Hold → Buy
2026-02-06 Aggiornamento JP Morgan Underweight → Neutral
2026-01-20 Aggiornamento Wells Fargo Equal Weight → Overweight
2026-01-09 Iniziato RBC Capital Mkts Outperform
2026-01-08 Aggiornamento Truist Hold → Buy
2025-12-15 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2025-12-09 Iniziato Barclays Overweight
2025-11-21 Aggiornamento Raymond James Outperform → Strong Buy
2025-11-13 Iniziato BMO Capital Markets Market Perform
2025-10-27 Aggiornamento BofA Securities Neutral → Buy
2025-10-10 Downgrade JP Morgan Neutral → Underweight
2025-10-01 Downgrade Goldman Neutral → Sell
2025-07-09 Aggiornamento Evercore ISI In-line → Outperform
2025-06-02 Aggiornamento BTIG Research Neutral → Buy
2025-02-07 Aggiornamento Leerink Partners Market Perform → Outperform
2025-02-07 Aggiornamento Piper Sandler Neutral → Overweight
2024-12-20 Iniziato Stephens Equal-Weight
2024-12-04 Iniziato Mizuho Neutral
2024-11-15 Iniziato Goldman Neutral
2024-11-14 Aggiornamento Morgan Stanley Underweight → Equal-Weight
2024-11-13 Downgrade Canaccord Genuity Buy → Hold
2024-11-08 Aggiornamento KeyBanc Capital Markets Sector Weight → Overweight
2024-11-08 Aggiornamento Wells Fargo Underweight → Equal Weight
2024-10-15 Aggiornamento Barclays Equal Weight → Overweight
2024-08-09 Aggiornamento Needham Hold → Buy
2024-07-18 Downgrade Wells Fargo Equal Weight → Underweight
2024-04-25 Aggiornamento JP Morgan Underweight → Neutral
2024-02-26 Iniziato Leerink Partners Market Perform
2024-01-03 Iniziato Barclays Equal Weight
2024-01-02 Aggiornamento BofA Securities Underperform → Neutral
2023-08-09 Downgrade Guggenheim Buy → Neutral
2023-08-09 Downgrade Needham Buy → Hold
2023-08-03 Downgrade Piper Sandler Overweight → Neutral
2023-05-01 Downgrade Wells Fargo Overweight → Equal Weight
2023-01-06 Downgrade Morgan Stanley Equal-Weight → Underweight
2022-10-31 Iniziato Wells Fargo Overweight
2022-10-24 Iniziato Evercore ISI In-line
2022-10-13 Iniziato BTIG Research Neutral
2022-09-16 Iniziato KeyBanc Capital Markets Sector Weight
2022-09-07 Iniziato Truist Hold
2022-08-05 Downgrade BofA Securities Neutral → Underperform
2022-07-28 Iniziato Berenberg Buy
2022-05-18 Reiterato BofA Securities Neutral
2022-05-18 Reiterato Goldman Buy
2022-05-18 Reiterato Guggenheim Buy
2022-05-18 Reiterato Jefferies Buy
2022-05-18 Reiterato Morgan Stanley Equal-Weight
2022-05-18 Reiterato Needham Buy
2022-04-07 Iniziato Guggenheim Buy
2022-04-04 Iniziato BofA Securities Neutral
2022-02-11 Iniziato Goldman Buy
2021-12-14 Downgrade JP Morgan Neutral → Underweight
2021-12-02 Iniziato Jefferies Buy
2021-11-17 Iniziato Robert W. Baird Outperform
2021-11-10 Reiterato Canaccord Genuity Buy
2021-11-10 Reiterato Goldman Neutral
2021-11-10 Reiterato Morgan Stanley Equal-Weight
2021-11-10 Reiterato Needham Buy
2021-11-10 Reiterato Piper Sandler Overweight
2021-08-26 Downgrade JP Morgan Overweight → Neutral
2021-07-19 Iniziato Canaccord Genuity Buy
2021-07-19 Iniziato Goldman Neutral
2021-07-19 Iniziato JP Morgan Overweight
2021-07-19 Iniziato Morgan Stanley Equal-Weight
2021-07-19 Iniziato Piper Sandler Overweight
2021-07-19 Iniziato Raymond James Outperform
2021-07-19 Iniziato SVB Leerink Outperform
2021-07-19 Iniziato William Blair Outperform
Mostra tutto

Doximity Inc Borsa (DOCS) Ultime notizie

pulisher
08:14 AM

Victory Capital Management Inc. Acquires 921,533 Shares of Doximity, Inc. $DOCS - MarketBeat

08:14 AM
pulisher
Mar 05, 2026

Doximity (NASDAQ:DOCS) Director Sells $52,000.00 in Stock - MarketBeat

Mar 05, 2026
pulisher
Mar 05, 2026

Assessing Doximity (DOCS) Valuation As Positive Analyst Sentiment Builds Around Its Telehealth Platform - simplywall.st

Mar 05, 2026
pulisher
Mar 05, 2026

Is Doximity Inc in accumulation or distribution phaseJuly 2025 Patterns & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

Mar 05, 2026
pulisher
Mar 05, 2026

Breakouts Watch: Is Doximity Inc stock a hidden gemWall Street Watch & Safe Capital Allocation Plans - baoquankhu1.vn

Mar 05, 2026
pulisher
Mar 05, 2026

Hims and Hers Expands Its Technology Driven Consumer Health Platform - TradingView

Mar 05, 2026
pulisher
Mar 04, 2026

DOCS SEC FilingsDoximity Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Doximity Analysts Set $44.50 Average Price Target - National Today

Mar 04, 2026
pulisher
Mar 03, 2026

Atlassian, C3.ai, Doximity, Braze, and Zeta Global Stocks Trade Up, What You Need To Know - Yahoo Finance

Mar 03, 2026
pulisher
Mar 03, 2026

DOCS (NYSE: DOCS) insider to sell 2,000 shares via option exercise - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Is It Time To Reassess Doximity (DOCS) After A 62.5% One Year Slide? - Yahoo Finance

Mar 03, 2026
pulisher
Mar 02, 2026

Is Doximity’s (DOCS) ViVE 2026 Pitch a Clue to Its Telehealth Moat? - simplywall.st

Mar 02, 2026
pulisher
Mar 02, 2026

Bentley Systems, Guidewire Software, Health Catalyst, and Doximity Shares Skyrocket, What You Need To Know - Finviz

Mar 02, 2026
pulisher
Mar 02, 2026

Intech Investment Management Trims Doximity Holdings - National Today

Mar 02, 2026
pulisher
Mar 02, 2026

Ad Vital’s Dr. Shitel Patel Shares AI Prompting Strategies for Patient Growth in Doximity Article - FinancialContent

Mar 02, 2026
pulisher
Mar 02, 2026

Doximity, Inc. (DOCS) Stock Analysis: Navigating a 62.87% Upside Potential in Health Information Services - DirectorsTalk Interviews

Mar 02, 2026
pulisher
Mar 02, 2026

Intech Investment Management LLC Has $3.57 Million Holdings in Doximity, Inc. $DOCS - MarketBeat

Mar 02, 2026
pulisher
Mar 01, 2026

William Blair Investment Management LLC Acquires 609,775 Shares of Doximity, Inc. $DOCS - MarketBeat

Mar 01, 2026
pulisher
Mar 01, 2026

Doximity, Inc. (NYSE:DOCS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Mar 01, 2026
pulisher
Mar 01, 2026

Andra AP fonden Makes New Investment in Doximity, Inc. $DOCS - MarketBeat

Mar 01, 2026
pulisher
Feb 28, 2026

Handelsbanken Fonder AB Acquires 180,700 Shares of Doximity, Inc. $DOCS - MarketBeat

Feb 28, 2026
pulisher
Feb 28, 2026

Doximity CEO ViVE 2026 Talk Puts AI And Pharma Story In Focus - Sahm

Feb 28, 2026
pulisher
Feb 27, 2026

Doximity, Inc. Hits New 52-Week Low at $23.57 Amid Market Decline - Markets Mojo

Feb 27, 2026
pulisher
Feb 26, 2026

Doximity Investors' $31M Deal Over User Slowdown OK'd - Law360

Feb 26, 2026
pulisher
Feb 26, 2026

ZoomInfo, SentinelOne, Toast, Doximity, and American Express Global Business Travel Shares Are Soaring, What You Need To Know - Yahoo Finance

Feb 26, 2026
pulisher
Feb 26, 2026

Doximity’s $31 Million Investor Settlement Clears Initial Hurdle - Bloomberg Law News

Feb 26, 2026
pulisher
Feb 25, 2026

Doximity Stock Hits Day Low of $23.58 Amid Price Pressure - Markets Mojo

Feb 25, 2026
pulisher
Feb 25, 2026

Doximity, Inc. Stock Plummets to New 52-Week Low of $23.58 - Markets Mojo

Feb 25, 2026
pulisher
Feb 25, 2026

Doximity Stock Analysts Adjust Ratings and Targets - National Today

Feb 25, 2026
pulisher
Feb 25, 2026

Doximity Expands AI Tools As Investors Weigh Profit Strength And Growth - Sahm

Feb 25, 2026
pulisher
Feb 25, 2026

Doximity, Inc. (NASDAQ:DOCS) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Feb 25, 2026
pulisher
Feb 24, 2026

Doximity (DOCS) Price Target Decreased by 31.04% to 44.25 - Nasdaq

Feb 24, 2026
pulisher
Feb 24, 2026

(DOCS) Risk Channels and Responsive Allocation - Stock Traders Daily

Feb 24, 2026
pulisher
Feb 23, 2026

Doximity stock hits 52-week low at $23.65 amid challenging year - Investing.com Australia

Feb 23, 2026
pulisher
Feb 23, 2026

Doximity (NASDAQ:DOCS) Sets New 12-Month Low on Analyst Downgrade - MarketBeat

Feb 23, 2026
pulisher
Feb 23, 2026

Got $50,000? This Unbelievable SaaS Compounder Is Hiding in Plain Sight. - The Motley Fool

Feb 23, 2026
pulisher
Feb 20, 2026

Piper Sandler raises Doximity stock price target on AI tools By Investing.com - Investing.com Australia

Feb 20, 2026
pulisher
Feb 20, 2026

Doximity (NASDAQ:DOCS) Price Target Lowered to $33.00 at JPMorgan Chase & Co. - MarketBeat

Feb 20, 2026
pulisher
Feb 20, 2026

Piper Sandler raises Doximity stock price target on AI tools - Investing.com

Feb 20, 2026
pulisher
Feb 20, 2026

Piper Sandler Forecasts Strong Price Appreciation for Doximity (NASDAQ:DOCS) Stock - MarketBeat

Feb 20, 2026
pulisher
Feb 20, 2026

Piper Sandler Raises Price Target for Doximity (DOCS) to $42 | D - GuruFocus

Feb 20, 2026
pulisher
Feb 19, 2026

Doximity Stock: Why Analysts Are Signaling a Buy After a 67% Drop Last Year - TIKR.com

Feb 19, 2026
pulisher
Feb 18, 2026

Doximity (DOCS) Soars 14% on Strong Earnings, Merger with AI-Powered Platform - MSN

Feb 18, 2026
pulisher
Feb 18, 2026

Why Doximity Stock Plummeted Today - AOL.com

Feb 18, 2026
pulisher
Feb 18, 2026

Canaccord Calls Doximity, Inc. (DOCS)’s Post-Earnings Selloff an Overreaction And Sees Long-Term Upside - Insider Monkey

Feb 18, 2026
pulisher
Feb 17, 2026

Canaccord Calls Doximity, Inc. (DOCS)'s Post-Earnings Selloff an Overreaction And Sees Long-Term Upside - Bitget

Feb 17, 2026
pulisher
Feb 16, 2026

Doximity Inc. (NYSE:DOCS) Fits the "Affordable Growth" Investment Strategy - ChartMill

Feb 16, 2026
pulisher
Feb 16, 2026

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 60% Upside Potential in the Healthcare Information Sector - DirectorsTalk Interviews

Feb 16, 2026
pulisher
Feb 14, 2026

How Doximity Inc. stock trades before earnings2025 AllTime Highs & Expert Verified Movement Alerts - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

How Doximity Inc. stock performs in weak economyExit Point & Trade Opportunity Analysis - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Doximity (DOCS) Is Down 9.8% After Big Buybacks and Mixed Q3 Signals Has The Bull Case Changed? - Yahoo Finance

Feb 14, 2026

Doximity Inc Azioni (DOCS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
health_information_services WAY
$25.71
price down icon 3.27%
$46.14
price up icon 0.65%
$23.27
price down icon 2.39%
health_information_services HQY
$78.36
price down icon 1.99%
health_information_services TXG
$20.81
price down icon 3.84%
Capitalizzazione:     |  Volume (24 ore):